Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeNeurOpticNew Study Results Show NeurOptics’ NPi-200 Pupillometer Provides Early Warning of Neurological...

New Study Results Show NeurOptics’ NPi-200 Pupillometer Provides Early Warning of Neurological Damage

A new study found that NeurOptics’ NPi®-200 Pupillometer, which provides an automated assessment of the pupillary light reflex, may signal an early warning of potential delayed cerebral ischemia and enable preemptive escalation of care. The study was published in the Journal of Neurosurgery.

The study analyzed 56 patients diagnosed with aneurysmal subarachnoid hemorrhage and admitted to the neuro-intensive care unit of the University of Texas Southwestern Medical Center between 2015 and 2017. Patients were monitored using transcranial Doppler and the infrared NPi-200 Pupillometer, which calculates a Neurological Pupil index (NPi). NPi values range from 0 to 5, with 3 or greater considered normal. Most patients had multiple daily NPi readings, and the lowest value was recorded.

The 635 paired observations of daily Doppler and NPi data showed a significant and strong association between the development of delayed cerebral ischemia and an abnormal decrease in NPi readings.1 Twelve patients experienced delayed cerebral ischemia, with seven showing a decrease in their NPi to an abnormal range. This change occurred more than eight hours prior to the clinical decline 71.4 percent of the time.1 The NPi normalized in all patients after treatment.

“Detecting and responding to neurological changes as early as possible is critical for patients,” said Dr. H. Hunt Batjer, M.D., F.A.C.S., the Lois C.A. and Darwin E. Smith Distinguished Chair in Neurological Surgery at UT Southwestern Medical Center. “These results showed that pupillometer changes may occur hours prior to the clinical neurological decline, and the NPi-200 has the potential to provide enough warning to initiate therapeutic measures before the development of irreversible neurological damage. Pupillometry may be a key piece to the larger picture when used as a complement to a good clinical, radiological, and sonographic examination.”

The aftermath of aneurysmal subarachnoid hemorrhage remains devastating despite modern advances in neurocritical care. Patients who do not succumb to the initial aneurysmal rupture are at risk for cerebral vasospasm, which occurs in about 70 percent of patients.2,3,4 Approximately 25 to 40 percent of these patients develop delayed cerebral ischemia, with neurological deficits and possible cognitive decline.3,5 Transcranial Doppler has been shown to be predictive of delayed cerebral ischemia,3 but with poor positive predictive value.

Automated assessment of the pupillary light reflex has emerged as an objective means of assessing pupillary reactivity across a broad spectrum of neurological disease, including stroke, traumatic brain injury and edema, tumoral herniation syndromes, and sports or war injuries. Pupillometers use infrared technology to assess an array of objective pupillary variables including size, constriction velocity, latency, and dilation velocity, which are normalized and standardized to compute the Neurological Pupil index. The NeurOptics NPi-200 Pupillometer eliminates the variability and subjectivity inherent in manual pupillary evaluation, providing more accurate, reliable, and objective pupil size and reactivity measurement for this vital component of neurological examinations.

The study, titled Detection of Delayed Cerebral Ischemia Using Objective Pupillometry in Patients with Aneurysmal Subarachnoid Hemorrhage, can be found here.


1. Aoun SG, Stutzman SE, Vo PN, et al. Detection of delayed cerebral ischemia using objective pupillometry in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019. Published online January 11, 2019; DOI: 10.3171/2018.9.JNS181928.
2. Dusick JR, Gonzalez NR. Management of arterial vasospasm following aneurysmal subarachnoid hemorrhage. Semin Neurol. 2013;33(05):488-497.
3. Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124(5):1257-1264.
4. Lysakowski C, Walder B, Costanza MC, Tramèr MR. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke. 2001;32(10):2292-2298.
5. D’Andrea A, Conte M, Cavallaro M, Scarafile R, Riegler L, Cocchia R, et al. Transcranial Doppler ultrasonography: from methodology to major clinical applications. World J Cardiol. 2016;8(7):383-400.
Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy